Slideshow

Endo News Roundup for February 2018

Author(s):

Three new diabetes studies highlight one risk, one potential prevention, and one possible new treatment.

Three new diabetes studies highlight one risk, one potential prevention, and one possible new treatment. This short slide show highlights: -- The impact of night shift work on risk of T2DM -- A potential role for methyldopa to prevent T1DM onset -- Use of a ketone ester supplement to lower blood sugar levels

Related Videos
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
© 2025 MJH Life Sciences

All rights reserved.